Safety and pharmacokinetics of motesanib in combination with gemcitabine for the treatment of patients with solid tumours

par Price, T J, Lipton, L, McGreivy, J, McCoy, S, Sun, Y-N, Rosenthal, M A
Publié 2008

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

par Byrd, J.C., Brown, J.R., O’Brien, S., Barrientos, J.C., Kay, N.E., Reddy, N.M., Coutre, S., Tam, C.S., Mulligan, S.P., Jaeger, U., Devereux, S., Barr, P.M., Furman, R.R., Kipps, T.J., Cymbalista, F., Pocock, C., Thornton, P., Caligaris-Cappio, F., Robak, T., Delgado, J., Schuster, S.J., Montillo, M., Schuh, A., de Vos, S., Gill, D., Bloor, A., Dearden, C., Moreno, C., Jones, J.J., Chu, A.D., Fardis, M., McGreivy, J., Clow, F., James, D.F., Hillmen, P.
Publié 2014